Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2022 Financial Results

Go back to Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2022 Financial Results
(NASDAQ: QNRX) Delayed: 4.41 -0.24 (5.16%)
Previous Close $4.65    52 Week High
Open $4.56    52 Week Low
Day High $4.83    P/E N/A 
Day Low $4.41    EPS
Volume 15,647